Xgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for XGEN PHARMS, and what generic and branded alternatives to XGEN PHARMS drugs are available?
XGEN PHARMS has eighteen approved drugs.
Drugs and US Patents for Xgen Pharms
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xgen Pharms | ACETAZOLAMIDE SODIUM | acetazolamide sodium | INJECTABLE;INJECTION | 040784-001 | Dec 10, 2008 | AP | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Xgen Pharms | LIOTHYRONINE SODIUM | liothyronine sodium | INJECTABLE;INJECTION | 076923-001 | Aug 17, 2005 | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Xgen Pharms | NEOMYCIN AND POLYMYXIN B SULFATE | neomycin sulfate; polymyxin b sulfate | SOLUTION;IRRIGATION | 065106-001 | Jan 31, 2006 | AT | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.